Niclas Lunder

415 total citations
10 papers, 355 citations indexed

About

Niclas Lunder is a scholar working on Molecular Biology, Pharmacology and Psychiatry and Mental health. According to data from OpenAlex, Niclas Lunder has authored 10 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Pharmacology and 3 papers in Psychiatry and Mental health. Recurrent topics in Niclas Lunder's work include Peroxisome Proliferator-Activated Receptors (3 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Pharmacological Effects and Toxicity Studies (2 papers). Niclas Lunder is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (3 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Pharmacological Effects and Toxicity Studies (2 papers). Niclas Lunder collaborates with scholars based in Norway, United Kingdom and Spain. Niclas Lunder's co-authors include Espen Molden, Rolf K. Berge, Silje Skrede, Johan Fernø, Vidar M. Steen, Hilde Lunde, Helge Refsum, Antonio Vidal‐Puig, Carlos Diéguez and Miguel López and has published in prestigious journals such as Psychopharmacology, Drug Metabolism and Disposition and Journal of Chromatography B.

In The Last Decade

Niclas Lunder

9 papers receiving 348 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Niclas Lunder Norway 7 133 96 82 67 62 10 355
Junzo Watanabe Japan 15 203 1.5× 112 1.2× 57 0.7× 38 0.6× 65 1.0× 31 466
Nobuto Tsuneyama Japan 12 161 1.2× 62 0.6× 51 0.6× 32 0.5× 73 1.2× 29 335
Patrizia Angelico Italy 15 74 0.6× 210 2.2× 127 1.5× 60 0.9× 102 1.6× 27 620
Robert L. Roe United States 11 55 0.4× 67 0.7× 125 1.5× 42 0.6× 114 1.8× 19 592
Michael J. Bly United States 9 157 1.2× 99 1.0× 99 1.2× 18 0.3× 66 1.1× 12 372
Jarbas S. Roriz‐Filho Brazil 7 55 0.4× 59 0.6× 178 2.2× 16 0.2× 117 1.9× 11 447
O Varoquaux France 12 71 0.5× 83 0.9× 67 0.8× 27 0.4× 14 0.2× 23 393
Joann L. Data United States 10 101 0.8× 149 1.6× 60 0.7× 52 0.8× 53 0.9× 12 538
Jaroslav Macášek Czechia 10 22 0.2× 120 1.3× 68 0.8× 57 0.9× 50 0.8× 21 453
Mahmoud M. Mohy El‐Din Egypt 13 50 0.4× 153 1.6× 103 1.3× 39 0.6× 79 1.3× 29 532

Countries citing papers authored by Niclas Lunder

Since Specialization
Citations

This map shows the geographic impact of Niclas Lunder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Niclas Lunder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Niclas Lunder more than expected).

Fields of papers citing papers by Niclas Lunder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Niclas Lunder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Niclas Lunder. The network helps show where Niclas Lunder may publish in the future.

Co-authorship network of co-authors of Niclas Lunder

This figure shows the co-authorship network connecting the top 25 collaborators of Niclas Lunder. A scholar is included among the top collaborators of Niclas Lunder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Niclas Lunder. Niclas Lunder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
2.
Robertsen, Ida, Pål Falck, Niclas Lunder, et al.. (2013). Endomyocardial, intralymphocyte, and whole blood concentrations of ciclosporin A in heart transplant recipients. PubMed. 2(1). 5–5. 8 indexed citations
3.
Molden, Espen, et al.. (2012). Metabolism of the Active Metabolite of Quetiapine, N-Desalkylquetiapine In Vitro. Drug Metabolism and Disposition. 40(9). 1778–1784. 29 indexed citations
4.
Skrede, Silje, María J. Vázquez, Audun Osland Vik‐Mo, et al.. (2011). Acute effects of orexigenic antipsychotic drugs on lipid and carbohydrate metabolism in rat. Psychopharmacology. 219(3). 783–794. 66 indexed citations
5.
Skrede, Silje, Johan Fernø, María J. Vázquez, et al.. (2011). Olanzapine, but not aripiprazole, weight-independently elevates serum triglycerides and activates lipogenic gene expression in female rats. The International Journal of Neuropsychopharmacology. 15(2). 163–179. 74 indexed citations
6.
Fernø, Johan, Audun Osland Vik‐Mo, Bjarte Håvik, et al.. (2008). Acute clozapine exposure in vivo induces lipid accumulation and marked sequential changes in the expression of SREBP, PPAR, and LXR target genes in rat liver. Psychopharmacology. 203(1). 73–84. 89 indexed citations
7.
Lunder, Niclas, et al.. (2008). Absolute ProGRP quantification in a clinical relevant concentration range using LC–MS/MS and a comprehensive internal standard☆. Journal of Chromatography B. 877(13). 1359–1365. 16 indexed citations
8.
Molden, Espen, Hilde Lunde, Niclas Lunder, & Helge Refsum. (2006). Pharmacokinetic Variability of Aripiprazole and the Active Metabolite Dehydroaripiprazole in Psychiatric Patients. Therapeutic Drug Monitoring. 28(6). 744–749. 66 indexed citations
9.
Lunder, Niclas, et al.. (2005). Kosttilskudd – forundringspakke i pilleform?. Tidsskrift for Den Norske Laegeforening.
10.
Lunder, Niclas, et al.. (2005). [Dietary supplements--surprise pills?].. PubMed. 125(6). 750–1. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026